永田祐二郎 (Yujiro Nagata) - マイポータル

基本情報

所属: 島根大学泌尿器科学講座講師

学位: 医学博士(2021年7月産業医科大学)

研究者番号: 40790853
J-GLOBAL ID: 202501017120728132
researchmap会員ID: R000082327

主要な論文

Sodium-Glucose Cotransporter 2 and Glucose Levels Affect Clear Cell Renal Cell Carcinoma Progression.

Yujiro Nagata, Ikko Tomisaki, Hisami Aono, Nguyen Thu Quynh, Eiji Kashiwagi, Naohiro Fujimoto

International journal of molecular sciences 26(12) 2025年6月8日査読有り筆頭著者責任著者
Prostate-specific Antigen Decline During Primary Androgen-deprivation Therapy for Predicting Response and Survival in Metastatic Castration-resistant Prostate Cancer Patients Receiving Enzalutamide.

Yujiro Nagata, Takaomi Sugi, Sohei Yamamura, Yoshihiro Sugita, Yui Mizushima, Takuo Matsukawa, Tomohisa Takaba, Kazumasa Jojima, Katsuyoshi Higashijima, Masahiro Matsumoto …

In vivo (Athens, Greece) 39(4) 2209-2218 2025年査読有り筆頭著者責任著者
Immunohistochemical Expression of p53 and FGFR3 Predicts Response to Enfortumab Vedotin in Metastatic Urothelial Carcinoma.

Yujiro Nagata, Akinori Minato, Hisami Aono, Rieko Kimuro, Katsuyoshi Higashijima, Ikko Tomisaki, Kenichi Harada, Hiroshi Miyamoto, Naohiro Fujimoto

International journal of molecular sciences 25(19) 2024年9月26日査読有り筆頭著者責任著者
Mineralocorticoid receptor signaling inhibits bladder cancer progression.

Yujiro Nagata, Takuro Goto, Yuki Teramoto, Takuo Matsukawa, Naohiro Fujimoto, Hiroshi Miyamoto

American journal of cancer research 14(2) 696-708 2024年査読有り筆頭著者
Melatonin Inhibits Chemical Carcinogen-mediated Malignant Transformation of Urothelial Cells: In Vitro Evidence.

Yujiro Nagata, Nguyen Thu Quynh, Hisami Aono, Kenichi Harada, Hiroshi Miyamoto, Naohiro Fujimoto

Cancer genomics & proteomics 21(4) 388-394 2024年査読有り筆頭著者責任著者
Initial-to-nadir Prostate-specific Antigen Ratio Predicts Response to First-line Enzalutamide in Metastatic Castration-resistant Prostate Cancer.

Yujiro Nagata, Kazumasa Jojima, Takuo Matsukawa, Ikko Tomisaki, Naohiro Fujimoto

Anticancer research 43(10) 4573-4581 2023年10月査読有り筆頭著者責任著者
Protective role of mineralocorticoid receptor signaling in urothelial tumorigenesis.

Yujiro Nagata, Takuo Matsukawa, Takuro Goto, Yuki Teramoto, Guiyang Jiang, Naohiro Fujimoto, Hiroshi Miyamoto

American journal of cancer research 13(2) 408-418 2023年査読有り筆頭著者
Prognostic Significance of 3-Month Prostate-specific Antigen Level Following Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer.

Yujiro Nagata, Takuo Matsukawa, Ikko Tomisaki, Naohiro Fujimoto

Anticancer research 42(2) 1107-1114 2022年2月査読有り筆頭著者責任著者
5α-Reductase Inhibitors Do Not Prevent the Development and Progression of Urothelial Cancer: In Vitro Evidence

Yujiro Nagata, Takuro Goto, Guiyang Jiang, Yuki Teramoto, Hiroshi Miyamoto

Bladder Cancer 6(4) 481-488 2020年9月9日査読有り筆頭著者
Effects of α1-adrenergic receptor antagonists on the development and progression of urothelial cancer.

Yujiro Nagata, Takashi Kawahara, Takuro Goto, Satoshi Inoue, Yuki Teramoto, Guiyang Jiang, Naohiro Fujimoto, Hiroshi Miyamoto

American journal of cancer research 10(12) 4386-4398 2020年査読有り筆頭著者

もっとみる

共同研究・競争的資金等の研究課題

淡明細胞型腎細胞癌における病理形態の形成メカニズムの解明

日本学術振興会科学研究費助成事業若手研究 2024年4月 - 2027年3月

永田祐二郎

永田祐二郎

基本情報

主要な論文

共同研究・競争的資金等の研究課題

メニュー

共著者の一覧